About Miranda Molenaar

This author has not yet written his bio.
Meanwhile let's just say that we are proud Miranda Molenaar contributed with 30 entries.

Entries by Miranda Molenaar

ISA to present key learnings for cancer vaccine development at the ESMO Immuno-Oncology Congress

ISA Pharmaceuticals Receives Fast Track Designation for Lead Product ISA101b

ISA Pharmaceuticals Commences Patient Treatment in Third Phase 2 Clinical Trial with the Combination of ISA101b and Libtayo® (cemiplimab)

ISA, in partnership with Erasmus MC, is awarded TKI grant and expands clinical pipeline

ISA announces successful closing of EUR 26 million funding round

ISA Pharmaceuticals Co-authors Publication in Nature Reviews Cancer on Therapeutic Cancer Vaccines

ISA has relocated to brand new Biopartner 5 building

ISA Pharmaceuticals selects product candidate for clinical trial with first in class COVID-19 immunotherapy

First Patient Treated in Phase II Combination Trial of ISA Pharmaceuticals’ Lead Immunotherapy ISA101b with Keytruda®